Retrospective study investigating the efficacy of use of Azacitidine and donor lymphocyte infusions (DLIs) in patients with acute myeloid leukemia, myelodysplastic syndrome or myeloproliferative syndrome after allogenic hematopoietic stem cell transplantation (allo-HSCT)

Trial Profile

Retrospective study investigating the efficacy of use of Azacitidine and donor lymphocyte infusions (DLIs) in patients with acute myeloid leukemia, myelodysplastic syndrome or myeloproliferative syndrome after allogenic hematopoietic stem cell transplantation (allo-HSCT)

Completed
Phase of Trial: Phase II

Latest Information Update: 05 Feb 2016

At a glance

  • Drugs Azacitidine (Primary) ; T cell replacement therapy (Primary)
  • Indications Acute myeloid leukaemia; Myelodysplastic syndromes; Myeloproliferative disorders
  • Focus Therapeutic Use
  • Most Recent Events

    • 05 Feb 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top